The Pre-Course to the Joint ACTRIMS-ECTRIMS Meeting - MS Virtual 2020
A Virtual Continuing Medical Education Program Provided by AcademicCME, European Charcot Foundation and EXCEMED
Supported by independent educational grants from Biogen, Janssen Neuroscience – Johnson & Johnson Company, and Sanofi Genzyme.
Agenda:
Wednesday, September 9th, 2020 | |
Virtual Module 1 | |
8:00 am – 8:20 am | How Genes and Environment Interact to Cause MS
Alberto Ascherio, MD |
8:20 am – 8:40 am | NMOSD
Kazuo Fujihara, MD |
8:40 am – 9:00 am | OCT and Neurofilaments in Clinical Practice
Peter Calabresi, MD |
9:00 am – 9:30 am | Faculty Discussion Q & A |
9:30 am – 9:50 am | Standard MRI to Monitor Disease Courses and Treatment Response
Douglas L. Arnold, MD |
9:50 am – 10:10 am | Advanced MRI to Monitor Disease Courses and Treatment Response
Nicola De Stefano, MD, PhD |
10:10 am – 10:30 am | The Spectrum of Treatments in RMS
Giancarlo Comi, MD, PhD |
10:30 am – 10:50 am | Enhancing Remyelination: From Basic Studies to Interventions
Hans-Peter Hartung, MD, PhD |
10.50 am -11.10 am | New Perspectives in Neurorehabilitation
Letizia Leocani, MD, PhD |
11.10 am – 11:30 am | Faculty Discussion Q & A and Conclusion |
Thursday, September 10th, 2020 | |
Virtual Module 2 | |
8:00 am – 8:20 am | Understanding Progressive MS
Fred D. Lublin, MD |
8:20 am – 8:40 am | Treatment Decisions in PMS
Per Soelberg Sorensen, MD |
8:40 am – 9:00 am | Neuroprotective Treatments
Giancarlo Comi, MD, PhD |
9:00 am – 9:30 am | Faculty Discussion Q & A |
9:30 am – 9:50 am | Are We Any Closer to Understanding the Cause of MS?
Peter Calabresi, MD |
9:50 am – 10:10 am | Electronic Data Capture/Devices – Can We Quantitate Disease Activity?
Jeffrey Cohen, MD |
10:10 am – 10:30 am | Is it Time to Consider Combination/Add-On Therapies?
Fred D. Lublin, MD |
10:30 am – 10:50 am | Are We Paying Enough Attention to Safety?
Hans-Peter Hartung, MD, PhD |
10:50 am – 11:30 am | Faculty Discussion Q & A and Conclusion |
Joint Accreditation Standards for Commercial Support
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement
AcademicCME designates this live material for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Through an agreement between the American Medical Association and the Union Européenne des Médecins Spécialistes, physicians may convert AMA PRA Category 1 Credit™ to an equivalent number of European CME Credits® (ECMECs®). These credits will be recognized by all National Accreditation Authorities in Europe with which the UEMS has a signed agreement of recognition of credits
CE Inquiries/Special Needs
For all CME inquiries or special needs, please contact [email protected] or 610-687-3300. There is no cost to attend this CME program. Pre-registration is strongly encouraged.
Financial Support
Supported by independent educational grants from Biogen, Janssen Neuroscience – Johnson & Johnson Company and Sanofi Genzyme.
Provided by AcademicCME, European Charcot Foundation and EXCEMED
Accredited by AcademicCME
Further details regarding how to tune into the virtual session will be provided by email prior to the event. Please email [email protected] with any questions.
Register